Imperva (IMPV) Misses Q2 EPS by 6c, FY Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Imperial Capital Cuts Price Target on Imperva (IMPV) to $50 Following 2Q; Reiterates Outperform
August 8, 2016 7:19 AM EDTImperial Capital maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $50.00 (from $55.00), following the company's 2Q earnings report. IMPV reported revenue of $57.9mn and adjusted net loss per share of $0.23. IMPV previously reported preliminary 2Q16 revenue of $57.5-58.0mn and adjusted... More
Wunderlich Securities Downgrades Imperva (IMPV) to Hold
August 5, 2016 8:00 AM EDTWunderlich Securities downgraded Imperva (NYSE: IMPV) from Buy to Hold.
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $45.01 yesterday.
... MoreNeedham & Company Upgrades Imperva (IMPV) to Buy Amid Potential Sale; $64 PT
August 5, 2016 7:27 AM EDTNeedham & Company upgraded Imperva (NYSE: IMPV) from Hold to Buy with a price target of $64.00, as Qatalyst hired for a potential sale.
Analyst Scott Zeller commented, "Our IMPV downgrade post MarQ was based on our lack of confidence that IMPV could achieve... More
Imperva (IMPV) to Review Strategic Alternatives
August 4, 2016 4:43 PM EDTImperva (NYSE: IMPV) announced that its Board of Directors has initiated a comprehensive review of strategic alternatives to enhance shareholder value. The Board has retained Qatalyst Partners as financial advisor and Fenwick & West as legal advisor to assist in the process.
Impervas Board is... More
